C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2011
12/08/2011	WO2011150855A1 Micro-rna biomarkers and methods for diagnosis of early colorectal carcinoma and high-grade adenoma
12/08/2011	WO2011150852A1 Compositions and methods for sequencing nucleic acids
12/08/2011	WO2011150833A1 Test tube, device comprising test tube and liquid treatment method by using same
12/08/2011	WO2011150675A1 Biochip comprising multiple microchannels
12/08/2011	WO2011150674A1 Testing method for drug sensitivity of mycobacterium tuberculosis, application of indicator and solid medium
12/08/2011	WO2011150545A1 Snps associated with polycystic ovary syndrome, chips comprising the same and use thereof
12/08/2011	WO2011150516A1 Diagnostic, screening and therapeutic applications of ocab-based tools
12/08/2011	WO2011150515A1 Prognostic markers for prostate cancer recurrence
12/08/2011	WO2011150509A2 Methods of diagnosing asthma
12/08/2011	WO2011150475A1 Optical mapping of genomic dna
12/08/2011	WO2011133036A3 Means and methods for determining risk of cardiovascular disease
12/08/2011	WO2011130691A3 Gna11 and gnaq exon 4 mutations in melanoma
12/08/2011	WO2011113895A3 Characterization and validation of inhibitors and ligands of dipeptidyl aminopeptidase iv (dp iv)
12/08/2011	WO2011112106A3 Urease test for detecting helicobacter pylori bacteria
12/08/2011	WO2011101744A3 Region of interest extraction and normalization methods
12/08/2011	WO2011097509A3 Hypoxia-related gene signatures for cancer classification
12/08/2011	WO2011094683A9 Method of identifying myelodysplastic syndromes
12/08/2011	WO2011091270A3 Biomarkers for lung disease monitoring
12/08/2011	WO2011085176A3 Fret-based method for the determination of protein phosphatase and kinase activity
12/08/2011	WO2011084703A3 Enzyme assays on a droplet actuator
12/08/2011	WO2011050981A3 Method for detecting balanced chromosomal aberrations in a genome
12/08/2011	WO2011048198A3 Method and rna reactor for exponential amplification of rna
12/08/2011	WO2010131193A8 Phosphodiesterase 9a as prostate cancer marker
12/08/2011	WO2010086782A8 Methods for the subclassification of breast tumours
12/08/2011	US20110302674 Methods and Compositions for the Improvement of Plant Tolerance to Environmental Stresses
12/08/2011	US20110302670 Polynucleotides and methods for the improvement of plants
12/08/2011	US20110302667 Transgenic brassica event mon 88302 and methods of use thereof
12/08/2011	US20110302665 Non-human mammals with t or b cells having predefined specificity
12/08/2011	US20110301535 Microfluidic control systems
12/08/2011	US20110301229 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/08/2011	US20110301227 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
12/08/2011	US20110301226 Compositions and methods for treating hepatic neoplasia
12/08/2011	US20110301224 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/08/2011	US20110301221 Diagnosis, prognosis and treatment of glioblastoma multiforme
12/08/2011	US20110301217 Selective Glycosidase Inhibitors and Uses Thereof
12/08/2011	US20110301186 Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease
12/08/2011	US20110301148 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
12/08/2011	US20110301145 Pyridazinones, method of making, and method of use thereof
12/08/2011	US20110301127 Methods of reducing microbial resistance to drugs
12/08/2011	US20110301110 TRIM33 (TIF1gamma) AS A NEW DIAGNOSTIC MARKER OF CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
12/08/2011	US20110301105 Compositions for proliferation of cells and related methods
12/08/2011	US20110301095 Methods and compositions for assessing and treating metastasis, metastatic cancer, and potential for metastasis
12/08/2011	US20110301093 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/08/2011	US20110301091 Compositions and methods for reducing the signs of aging of the skin
12/08/2011	US20110301056 Nectin-4 for target genes of cancer therapy and diagnosis
12/08/2011	US20110301055 Methods for determining a prognosis in multiple myeloma
12/08/2011	US20110301050 Dna hypermethylation brain cancer markers
12/08/2011	US20110301048 Diagnosis and prognosis of breast cancer patients
12/08/2011	US20110301047 Sensing device for sensing a fluid
12/08/2011	US20110301046 Methods of Determining Efficacy of Glucocorticoid Treatment of Eosinophilic Esophagitis
12/08/2011	US20110301045 Composition and Methods Related to Modification of 5-Hydroxymethylcytosine (5-hmC)
12/08/2011	US20110301043 Risk assessment for cutaneous adverse drug reactions from antiretroviral agent
12/08/2011	US20110301042 Methods of sample encoding for multiplex analysis of samples by single molecule sequencing
12/08/2011	US20110301041 Modified Proteins and Methods of Making and Using Same
12/08/2011	US20110300600 Methods and compositions for delivering polynucleotides
12/08/2011	US20110300574 Cell-counting method for blood hemolysis analysis in fragility measurement
12/08/2011	US20110300573 Method to characterize blood and red blood cells via erythrocyte membrane fragility quantification
12/08/2011	US20110300572 In vitro method and apparatus for determining efficacy and action mechanisms of a topical composition on various skin color types
12/08/2011	US20110300571 Determination of the Liver Toxicity of an Agent
12/08/2011	US20110300570 Method and system for generating spatially and temporally controllable concentration gradients
12/08/2011	US20110300569 Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (rtca) cardio instruments
12/08/2011	US20110300568 Systems and methods for processing algae cultivation fluid
12/08/2011	US20110300567 Method for determining redox activity and screening compounds based on redox activity
12/08/2011	US20110300566 Methods for screening for histone deacetylase activity and for identifying histone deacetylase inhibitors
12/08/2011	US20110300565 Analysis method, analysis device, program used to implement said analysis method, and storage medium and retrieval device for this program
12/08/2011	US20110300554 Exponential isothermal self-sustained replication of an rna enzyme
12/08/2011	US20110300553 Engineering complex microbial phenotypes with successive integrations of exogenous dna (siedna)
12/08/2011	US20110300552 Systems and Methods for Determining Drug Resistance in Microorganisms
12/08/2011	US20110300551 Method of predicting clinical outcomes for melanoma patients using circulating melanoma cells in blood
12/08/2011	US20110300550 Method for detecting nucleic acid in biological sample
12/08/2011	US20110300549 Treatment of Development-Related Disorders
12/08/2011	US20110300548 Gdf15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes
12/08/2011	US20110300547 Method of utilizing the pts gene and anti-sense ads to increase patchouli alcohol content in artemisia annua l.
12/08/2011	US20110300546 Method of utilizing the pts gene and rna interference of the ads gene to increase patchouli alcohol content in artemisia annua l.
12/08/2011	US20110300545 Primers for the rapid and specific detection of propane-oxidizing and butane-oxidizing microorganisms and methods of using same
12/08/2011	US20110300544 Enhanced taqman probe based amplification
12/08/2011	US20110300543 Methods for making induced pluripotent stem cells from mesenchymal stem cells
12/08/2011	US20110300542 Gene Expression Profiling For Identification, Monitoring And Treatment Of Multiple Sclerosis
12/08/2011	US20110300541 Detection and typing of bacterial strains
12/08/2011	US20110300540 Methods and probe combinations for detecting melanoma
12/08/2011	US20110300539 Method for Detecting Polymorphism at Nucleotide Position -1639 of VKORC1 Gene, and Nucleic Acid Probe and Kit Therefor
12/08/2011	US20110300538 Bifidobacteria crispr sequences
12/08/2011	US20110300537 Methods of detecting sequence differences
12/08/2011	US20110300536 Gene marker and method for detection of oral cancer
12/08/2011	US20110300535 Method of identifying individuals at risk of thiopurine drug resistance and intolerance
12/08/2011	US20110300534 Compositions and methods for sequencing nucleic acids
12/08/2011	US20110300533 Yeast Screens for Treatment of Human Disease
12/08/2011	US20110300532 Control of the toxicity of gold nanoparticles
12/08/2011	US20110300531 Method and device to detect the presence of analytes in a sample
12/08/2011	US20110300530 In vitro test system for viral infections
12/08/2011	US20110300529 Detection of ifi16 in body fluids
12/08/2011	US20110300528 Methods for Bacteriophage Design
12/08/2011	US20110300282 Production of monatin enantiomers
12/08/2011	US20110300232 EFFECTS OF NITRIC OXIDE (NO) AND iNOS ON EXPRESSION AND SIGNAL TRANSDUCTION IN CANCER AND ITS USE IN DRUG DISCOVERY AND CANCER THERAPY DESIGN
12/08/2011	US20110300222 Luminescent porous silicon nanoparticles, methods of making and using same
12/08/2011	US20110300206 Vaccines against chlamydial infection
12/08/2011	US20110300178 Hpv types and variants associated with cervical cancer and the uses thereof
12/08/2011	US20110300164 Immunostimulatory dna:rna oligonucleotides
12/08/2011	US20110300161 Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma
12/08/2011	US20110300155 Modulating xrn2

1 ... 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 ... 3003